MSB 1.29% $1.18 mesoblast limited

A cynic reviews MSB's lower back pain trials.

  1. 1,068 Posts.
    lightbulb Created with Sketch. 18
    This item appeared on the BBC’s Trust Me I'm a Doctor a couple of weeks ago, featuring a patient in the Phase 2 trial and someone who has enrolled in the Phase 3 . The BBC reporter , a surgeon, admits she is cynical ….her findings are interesting and her comments on the quality of the trial illuminating. Watching this, it is not hard to understand why MSB reports considerable corporate interest in the trial . This can hardly be surprising given the lack of alternatives and suggests that if it clears Phase 3 , could potentially create a market worth billions.
    http://www.bbc.co.uk/programmes/art...-injection-of-stem-cells-repair-damaged-backs
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.18
Change
0.015(1.29%)
Mkt cap ! $1.347B
Open High Low Value Volume
$1.15 $1.20 $1.15 $4.551M 3.886M

Buyers (Bids)

No. Vol. Price($)
2 98246 $1.17
 

Sellers (Offers)

Price($) Vol. No.
$1.18 19079 2
View Market Depth
Last trade - 16.10pm 16/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.